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Abstract
CLINICAL RESEARCH THAT ADDRESSES THE CHALLENGES OF  
ANALYZING LARGE-SCALE MEDICAL DATA
Atsushi Goto
Department of Health Data Science, Graduate School of Data Science, Yokohama City University
　In recent years, omics data such as genomic information and metabolomic information, as well as health screening 
and medical data, have been accumulated in large-scale databases. In the healthcare field, it is expected that various 
problems can be solved by using this large-scale medical data. However, there are many challenges in analyzing such 
large-scale medical data at present. To introduce methods to overcome the challenges of using vast amounts of 
healthcare data, this article outlines (1) the construction of healthcare databases by collecting high-quality data, (2) 
the accumulation of validation data, and (3) addressing unobserved and unmeasured confounding.
